NCT03027505

Brief Summary

MUAC only is a pilot trial external control carried out between January 2017 and December 2017 in the Yako district (northern region), Burkina Faso. The objective of this study is to evaluate an integrated protocol for acute malnourished children without medical complication. The hypotheses of the integrated protocol include :

  1. 1.A global treatment of acute malnutrition (moderate and severe) with a single treatment (RUTF) would improve the functioning of the program through early identification of acutely malnourished children, while achieving a better coverage and using a single supply chain.
  2. 2.A gradual reduction of RUTF dosage according to a child's MUAC status could significantly increase the number of children on treatment without increasing overall RUTF quantity while maintaining similar recovery rates.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,958

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

January 17, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 23, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

January 30, 2019

Status Verified

January 1, 2019

Enrollment Period

11 months

First QC Date

January 17, 2017

Last Update Submit

January 29, 2019

Conditions

Keywords

MUACAcute malnutritionRUTFChildrenBurkina Faso

Outcome Measures

Primary Outcomes (1)

  • Recovery rate

    The recovery is defined as below : * Minimum of 4 weeks of participation in the program * MUAC\> = 125 mm on 2 consecutive visits * No edema for minimum 2 weeks * Good Clinical Health

    Between 4 and 12 weeks

Secondary Outcomes (6)

  • Mortality rate

    Between inclusion and week 12

  • Default rate

    Between 3 and 12 weeks

  • Non-respondent rate

    12 weeks after inclusion

  • Hospitalization rate

    Between inclusion and week 12

  • Relapse rate

    up to 3 months

  • +1 more secondary outcomes

Study Arms (1)

MUAC<125mm

EXPERIMENTAL

no medical complication

Drug: Ready to Use Therapeutic Food (RUTF)

Interventions

MUAC used as the primary admission and exit criteria for children with MUAC \<125mm and no medical complication. Single treatment of RUTF for severe and moderate malnourished children and gradual reduction of doses according to the MUAC and the weight of the child during treatment. MUAC split into 3 categories: * MUAC \<115 mm: 175 kcal /kg/day * 115 \<MUAC \<120mm: 125kcal/kg/day * 120 \<MUAC \<125mm: 75kcal/kg/day

Also known as: MUAC<125mm
MUAC<125mm

Eligibility Criteria

Age6 Months - 59 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Being between 6 and 59 months old
  • New admission
  • Acute malnutrition defined as follows:
  • MUAC\<125mm
  • MUAC\> 125mm AND WHZ (Z-score) \<-3 (WHO standard)
  • Edema
  • Resident in the study area (Yako district)
  • Signed informed consent of the mother or the child's guardian

You may not qualify if:

  • Children allergic to milk, peanuts and / or RUTF

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ALIMA

Yako, Nord Region, Burkina Faso

Location

Study Officials

  • Susan Shepherd, MD

    Directrice de recherches Opérationnelles et Médicales, ALIMA, USA

    PRINCIPAL INVESTIGATOR
  • Renaud Becquet, MPH,PhD,HDR

    Chercheur Inserm, Inserm U1219 Bordeaux Population Health Center-Université de Bordeaux

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2017

First Posted

January 23, 2017

Study Start

January 1, 2017

Primary Completion

December 1, 2017

Study Completion

April 1, 2018

Last Updated

January 30, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations